BioHarvest Sciences Inc. Announces a Private Placement of up to USD $5 Million of Convertible Notes to Finance Production Facilities and Scaling of Core Business Company News
EQUITY NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages AbbVie Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Announces the Filing of A Securities Fraud Class Action Lawsuit Against AbbVie, Inc. Pharmaceutical Investing
Bioharvest Sciences Inc. Reports Strong Q1 2022 Results on All of the Company's Activities Company News
AUPH INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma Pharmaceutical Investing
Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY 1.25% in Adults with Age-Related Blurry Near Vision Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo with Chemotherapy as First-Line Treatment for Patients with... Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo Plus Yervoy as First-Line Treatment for Patients with... Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma with Tumor Cell PD-L1 Expression ?1% Pharmaceutical Investing
